Search Results - "Silverman, Richard"

Refine Results
  1. 1

    Design and Mechanism of GABA Aminotransferase Inactivators. Treatments for Epilepsies and Addictions by Silverman, Richard B

    Published in Chemical reviews (11-04-2018)
    “…When the brain concentration of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) diminishes below a threshold level, the excess neuronal excitation…”
    Get full text
    Journal Article
  2. 2

    Inducible nitric oxide synthase: Regulation, structure, and inhibition by Cinelli, Maris A., Do, Ha T., Miley, Galen P., Silverman, Richard B.

    Published in Medicinal research reviews (01-01-2020)
    “…A considerable number of human diseases have an inflammatory component, and a key mediator of immune activation and inflammation is inducible nitric oxide…”
    Get full text
    Journal Article
  3. 3

    Design of Selective Neuronal Nitric Oxide Synthase Inhibitors for the Prevention and Treatment of Neurodegenerative Diseases by Silverman, Richard B

    Published in Accounts of chemical research (17-03-2009)
    “…Nitric oxide (NO), which is produced from l-arginine by the nitric oxide synthase (NOS) family of enzymes, is an important second-messenger molecule that…”
    Get full text
    Journal Article
  4. 4

    From Basic Science to Blockbuster Drug: The Discovery of Lyrica by Silverman, Richard B

    Published in Angewandte Chemie (International ed.) (28-04-2008)
    “…The anticonvulsant drug (S)‐(+)‐3‐isobutyl‐γ‐aminobutyric acid ((S)‐(+)‐3‐isobutyl‐GABA, Lyrica; see structure) was developed from a study of fundamental…”
    Get full text
    Journal Article
  5. 5

    Inactivators of Ornithine Aminotransferase for the Treatment of Hepatocellular Carcinoma by Silverman, Richard B

    Published in ACS medicinal chemistry letters (13-01-2022)
    “…Hepatocellular carcinoma (HCC) is the second or third leading cause of cancer mortality worldwide (depending on which statistics are used), yet there is no…”
    Get full text
    Journal Article
  6. 6

    Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain by Mukherjee, Paramita, Cinelli, Maris A, Kang, Soosung, Silverman, Richard B

    Published in Chemical Society reviews (07-10-2014)
    “…Nitric oxide (NO) is an important signaling molecule in the human body, playing a crucial role in cell and neuronal communication, regulation of blood…”
    Get more information
    Journal Article
  7. 7
  8. 8

    American Academy of Orthopaedic Surgeons Clinical Practice Guideline Case Study: Management of Anterior Cruciate Ligament Injuries by Brophy, Robert H., Silverman, Richard M., Lowry, Kent Jason

    “…Considering the frequency of anterior cruciate ligament (ACL) tears, optimal management of these injuries was the subject of a 2022 clinical practice guideline…”
    Get full text
    Journal Article
  9. 9
  10. 10

    The Sirtuin 2 Inhibitor AK-7 Is Neuroprotective in Huntington’s Disease Mouse Models by Chopra, Vanita, Quinti, Luisa, Kim, Jinho, Vollor, Lorraine, Narayanan, K. Lakshmi, Edgerly, Christina, Cipicchio, Patricia M., Lauver, Molly A., Choi, Soo Hyuk, Silverman, Richard B., Ferrante, Robert J., Hersch, Steven, Kazantsev, Aleksey G.

    Published in Cell reports (Cambridge) (27-12-2012)
    “…Inhibition of sirtuin 2 (SIRT2) deacetylase mediates protective effects in cell and invertebrate models of Parkinson’s disease and Huntington’s disease (HD)…”
    Get full text
    Journal Article
  11. 11

    Potent, Selective, and Membrane Permeable 2‑Amino-4-Substituted Pyridine-Based Neuronal Nitric Oxide Synthase Inhibitors by Vasu, Dhananjayan, Do, Ha T., Li, Huiying, Hardy, Christine D., Awasthi, Amardeep, Poulos, Thomas L., Silverman, Richard B.

    Published in Journal of medicinal chemistry (27-07-2023)
    “…A series of potent, selective, and highly permeable human neuronal nitric oxide synthase inhibitors (hnNOS), based on a difluorobenzene ring linked to a…”
    Get full text
    Journal Article
  12. 12

    Synthesis of (2R,4S)‑4-Amino-5-hydroxybicyclo[3.1.1]heptane-2-carboxylic Acid via an Asymmetric Intramolecular Mannich Reaction by Dukes, Adrian O., Weerawarna, Pathum M., Devitt, Allison N., Silverman, Richard B.

    Published in Journal of organic chemistry (21-06-2024)
    “…Inhibition of human ornithine aminotransferase interferes with glutamine and proline metabolism in hepatocellular carcinoma, depriving tumors of essential…”
    Get full text
    Journal Article
  13. 13

    Improved synthesis and anticancer activity of a potent neuronal nitric oxide synthase inhibitor by Vasu, Dhananjayan, Reidl, Cory T., Wang, Eric, Yang, Sun, Silverman, Richard B.

    Published in Bioorganic & medicinal chemistry letters (15-06-2023)
    “…[Display omitted] An improved synthesis of 4-methyl-7-(3-((methylamino)methyl)phenethyl)quinolin-2-amine (1) is reported. A scalable, rapid, and efficient…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Optimization of Blood–Brain Barrier Permeability with Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibitors Having a 2‑Aminopyridine Scaffold by Do, Ha T, Li, Huiying, Chreifi, Georges, Poulos, Thomas L, Silverman, Richard B

    Published in Journal of medicinal chemistry (14-03-2019)
    “…Effective delivery of therapeutic drugs into the human brain is one of the most challenging tasks in central nervous system drug development because of the…”
    Get full text
    Journal Article
  16. 16

    2-Aminopyridines with a shortened amino sidechain as potent, selective, and highly permeable human neuronal nitric oxide synthase inhibitors by Vasu, Dhananjayan, Li, Huiying, Hardy, Christine D., Poulos, Thomas L., Silverman, Richard B.

    Published in Bioorganic & medicinal chemistry (01-09-2022)
    “…[Display omitted] A series of potent, selective, and highly permeable human neuronal nitric oxide synthase inhibitors (hnNOS) based on the 2-aminopyridine…”
    Get full text
    Journal Article
  17. 17

    First Contact: 7‑Phenyl-2-Aminoquinolines, Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors That Target an Isoform-Specific Aspartate by Cinelli, Maris A, Reidl, Cory T, Li, Huiying, Chreifi, Georges, Poulos, Thomas L, Silverman, Richard B

    Published in Journal of medicinal chemistry (14-05-2020)
    “…Inhibition of neuronal nitric oxide synthase (nNOS), an enzyme implicated in neurodegenerative disorders, is an attractive strategy for treating or preventing…”
    Get full text
    Journal Article
  18. 18

    CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease by Kang, Soosung, Cooper, Garry, Dunne, Sara F., Dusel, Brendon, Luan, Chi-Hao, Surmeier, D. James, Silverman, Richard B.

    Published in Nature communications (23-10-2012)
    “…L-type calcium channels expressed in the brain are heterogeneous. The predominant class of L-type calcium channels has a Ca V 1.2 pore-forming subunit. L-type…”
    Get full text
    Journal Article
  19. 19

    Editorial Commentary: Preoperative Patient-Reported Outcomes Measurement Information System Scores Predict Which Patients Will Benefit From Arthroscopic Meniscectomy: To Scope or Not to Scope? by Silverman, Richard M, Matava, Matthew J

    Published in Arthroscopy (01-03-2021)
    “…Despite its widespread use and low complication rates, arthroscopic meniscectomy has not been uniformly successful in all patients, especially in those with…”
    Get full text
    Journal Article
  20. 20

    Interaction of Candida albicans Cell Wall Als3 Protein with Streptococcus gordonii SspB Adhesin Promotes Development of Mixed-Species Communities by Silverman, Richard J, Nobbs, Angela H, Vickerman, M. Margaret, Barbour, Michele E, Jenkinson, Howard F

    Published in Infection and Immunity (01-11-2010)
    “…Candida albicans colonizes human mucosa and prosthetic surfaces associated with artificial joints, catheters, and dentures. In the oral cavity, C. albicans…”
    Get full text
    Journal Article